Cargando…

Antibodies, epicenter of SARS-CoV-2 immunology

Detalles Bibliográficos
Autores principales:	Pecetta, Simone, Pizza, Mariagrazia, Sala, Claudia, Andreano, Emanuele, Pileri, Piero, Troisi, Marco, Pantano, Elisa, Manganaro, Noemi, Rappuoli, Rino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835663/ https://www.ncbi.nlm.nih.gov/pubmed/33500559 http://dx.doi.org/10.1038/s41418-020-00711-w

Ejemplares similares

Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
por: Andreano, Emanuele, et al.
Publicado: (2021)

High-throughput bactericidal assays for monoclonal antibody screening against antimicrobial resistant Neisseria gonorrhoeae
por: Stazzoni, Samuele, et al.
Publicado: (2023)

Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
por: Andreano, Emanuele, et al.
Publicado: (2022)

Save the microbes to save the planet. A call to action of the International Union of the Microbiological Societies (IUMS)
por: Rappuoli, Rino, et al.
Publicado: (2023)

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
por: Torres, Jonathan L., et al.
Publicado: (2022)

Immunodominant antibody germlines in COVID-19
por: Andreano, Emanuele, et al.
Publicado: (2021)

A new dawn for monoclonal antibodies against antimicrobial resistant bacteria
por: Troisi, Marco, et al.
Publicado: (2022)

B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response
por: Andreano, Emanuele, et al.
Publicado: (2023)

Vaccinology in the post−COVID-19 era
por: Rappuoli, Rino, et al.
Publicado: (2021)

mRNA, the beginning of a new influenza vaccine game
por: Pecetta, Simone, et al.
Publicado: (2022)

Vaccinology – Editorial
por: Pizza, Mariagrazia, et al.
Publicado: (2020)

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
por: Andreano, Emanuele, et al.
Publicado: (2021)

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
por: Andreano, Emanuele, et al.
Publicado: (2021)

SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma
por: Andreano, Emanuele, et al.
Publicado: (2020)

LytM Proteins Play a Crucial Role in Cell Separation, Outer Membrane Composition, and Pathogenesis in Nontypeable Haemophilus influenzae
por: Ercoli, Giuseppe, et al.
Publicado: (2015)

Newborns of COVID-19 mothers: short-term outcomes of colocating and breastfeeding from the pandemic’s epicenter
por: Patil, Uday P., et al.
Publicado: (2020)

Vaccines against Meningococcal Diseases
por: Pizza, Mariagrazia, et al.
Publicado: (2020)

mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5
por: Andreano, Emanuele, et al.
Publicado: (2023)

Corrigendum: Vaccines Against Antimicrobial Resistance
por: Rosini, Roberto, et al.
Publicado: (2020)

Vaccines Against Antimicrobial Resistance
por: Rosini, Roberto, et al.
Publicado: (2020)

Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis
por: Baldari, Cosima T., et al.
Publicado: (2023)

Vaccine Evolution and Its Application to Fight Modern Threats
por: Andreano, Emanuele, et al.
Publicado: (2019)

2D NMR Analysis as a Sensitive Tool for Evaluating the Higher-Order Structural Integrity of Monoclonal Antibody against COVID-19
por: Cantini, Francesca, et al.
Publicado: (2022)

Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions
por: Vacca, Fabiola, et al.
Publicado: (2022)

Transforming vaccine development
por: Black, Steve, et al.
Publicado: (2020)

Conservation of Meningococcal Antigens in the Genus Neisseria
por: Muzzi, Alessandro, et al.
Publicado: (2013)

SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly
por: Onnis, Anna, et al.
Publicado: (2022)

Swarm immunology: harnessing blockchain technology and artificial intelligence in human immunology
por: Schultze, Joachim L., et al.
Publicado: (2022)

Vaccines for the future: learning from human immunology
por: De Gregorio, Ennio, et al.
Publicado: (2012)

Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Nicotiana benthamiana
por: Frigerio, Rachele, et al.
Publicado: (2022)

Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
por: Mokhtary, Pardis, et al.
Publicado: (2022)

Escherichia coli: Great Diversity around a Common Core
por: Moriel, Danilo G., et al.
Publicado: (2012)

Immunological considerations for SARS-CoV-2 human challenge studies
por: Douglas, Alexander D., et al.
Publicado: (2020)

Lipid scrambling in immunology: why it is important
por: Wu, Ning, et al.
Publicado: (2023)

The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium
por: Aquino, Erika Neves, et al.
Publicado: (2023)

The immunological interplay between vaccination and the intestinal microbiota
por: Zimmermann, Petra
Publicado: (2023)

Immunological consequences of arsenic trioxide-induced necrosis
por: Gavali, Shubhangi, et al.
Publicado: (2023)

A paradox of social distancing for SARS-CoV-2: loneliness and heightened immunological risk
por: Rozenkrantz, Liron, et al.
Publicado: (2020)

Open questions: a few that need answers in immunology
por: Stockinger, Brigitta
Publicado: (2013)

Exploiting an early immunological window of opportunity in COVID-19
por: Russell, Clark D
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bf2b6lahal39gfu58jqgmmk291